Compare Lautan Luas Tbk. (LTLS) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lautan Luas Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Lautan Luas Tbk. trades at Rp1,075 (market cap 1.64T, 350.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Lautan Luas Tbk. is far larger — about 15.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LTLS | SCPI | |
|---|---|---|
Market Cap | 1.64T | 104.4B |
Volume | 350.8K | — |
Lot | 3.51K | — |
Turnover | 373.61M | — |
Average Price | 1,065.03 | — |
Value | 373.61M | — |
Indicative Equilibrium Price | 1,075 | — |
Indicative Equilibrium Volume | 9 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lautan Luas Tbk.
PT Lautan Luas Tbk (the Company) was established under the name of Persekutuan Andil Maskapai Dagang dan Industri Lim Teck Lee Coy Ltd (Indonesia) based on notarial deed No. 75 dated January 18, 1951 of Raden Mas Soerojo. PT. Lautan Luas is a distributor and manufacturer - specialty and basic chemical.
Read more on LTLS →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
